Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 2
2010 1
2011 3
2012 3
2013 1
2014 8
2015 5
2016 4
2017 2
2018 3
2019 3
2020 5
2021 13
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Idiopathic Aplastic anemia: Indian Perspective.
Dolai TK, Jain M, Mahapatra M. Dolai TK, et al. Indian J Hematol Blood Transfus. 2023 Jul;39(3):357-370. doi: 10.1007/s12288-022-01592-4. Epub 2022 Oct 31. Indian J Hematol Blood Transfus. 2023. PMID: 37304471 Review.
Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method.
Mathews V, Korula A, Chakrapani A, Bhurani D, Bhattacharyya J, Sengar M, Malhotra P, Boyella PK, Singh PK, Ganesan P, Dhawan R, Melinkeri S, Damodar S, Dolai TK, Radhakrishnan V. Mathews V, et al. Among authors: dolai tk. Front Oncol. 2023 Apr 24;13:1171568. doi: 10.3389/fonc.2023.1171568. eCollection 2023. Front Oncol. 2023. PMID: 37168381 Free PMC article. Review.
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India.
Patel A, Bhatt N, Prakash SS, Biswas G, Nagarkar R, Roy B, Samal P, Agrawal N, Meshram S, Kaushal A, Satheesh CT, Wategaonkar R, Thiagarajan KV, Jain K, Vijayaveeran P, Mukherjee K, Singh K, Patil T, Jain A, Dolai TK, Jain M, Hingmire S, Gupta TC, Lakshmaiah KC, Rajamanickam D, Nemade B, Goyal V, Mahato P, Mendiratta SK, Doshi M. Patel A, et al. Among authors: dolai tk. Cancer Chemother Pharmacol. 2023 Jun;91(6):457-468. doi: 10.1007/s00280-023-04530-x. Epub 2023 Apr 24. Cancer Chemother Pharmacol. 2023. PMID: 37093266 Free PMC article. Clinical Trial.
Lenalidomide-induced pure red cell aplasia.
Dolai TK, Dutta S, Mandal PK, Saha S, Bhattacharyya M. Dolai TK, et al. Turk J Haematol. 2014 Mar;31(1):99-100. doi: 10.4274/Tjh.2013.0207. Epub 2014 Mar 5. Turk J Haematol. 2014. PMID: 24764740 Free PMC article. No abstract available.
Veno-occlusive disease following high dose melphalan.
Dolai TK, Nataraj KS, Bhattacharya M, Ghosh MK. Dolai TK, et al. Indian J Hematol Blood Transfus. 2012 Mar;28(1):62-3. doi: 10.1007/s12288-011-0100-4. Epub 2011 Aug 18. Indian J Hematol Blood Transfus. 2012. PMID: 23449090 Free PMC article.
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study.
Delimpasi S, Mateos MV, Auner HW, Gavriatopoulou M, Dimopoulos MA, Quach H, Pylypenko H, Hájek R, Leleu X, Dolai TK, Sinha DK, Venner CP, Benjamin R, Garg MK, Doronin V, Levy Y, Moreau P, Chai Y, Arazy M, Shah J, Shacham S, Kauffman MG, Richardson PG, Grosicki S. Delimpasi S, et al. Among authors: dolai tk. Am J Hematol. 2022 Mar 1;97(3):E83-E86. doi: 10.1002/ajh.26434. Epub 2021 Dec 29. Am J Hematol. 2022. PMID: 34882831 Free article. Clinical Trial. No abstract available.
Disappearing bone in multiple myeloma.
Dolai TK, Dutta S, Mandal PK. Dolai TK, et al. Indian J Pathol Microbiol. 2013 Apr-Jun;56(2):178-9. doi: 10.4103/0377-4929.118693. Indian J Pathol Microbiol. 2013. PMID: 24056663 No abstract available.
53 results